Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
wet AMD
Pharma
FDA gives thumbs-up to Roche's Susvimo as treatment for DME
The FDA has broadened the label of Roche's eye implant Susvimo to treat diabetic macular edema, the leading cause of diabetes-related blindness.
Kevin Dunleavy
Feb 4, 2025 3:15pm
Clearside's CLS-AX excels in phase 2b trial, set for phase 3
Oct 9, 2024 11:47am
Roche to reintroduce eye implant Susvimo 2 years after recall
Jul 8, 2024 5:10pm
Genentech animated short spotlights docs' trust in Vabysmo
May 13, 2024 4:05pm
Roche's Vabysmo shows durability in retinal vein occlusion
Oct 10, 2023 10:21am
Battling Roche's Vabysmo, Regeneron's Eylea shows durability
Aug 10, 2023 11:44am
